COMPASS Pathways plc
Total Trades
25
Buys
0
Sells
23
Largest Trade
N/A
Insiders
5
Institutional Funds
136
Inst. Value
$1M+
Activist Filings
28
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Malievskaia Ekaterina | 10% Owner | SELL | N/A | 1.6M | — | Oct 25, 2024 |
| Goldsmith George Jay | 10% Owner | SELL | N/A | 1.6M | — | Oct 25, 2024 |
| ATAI Life Sciences N.V. | 10% Owner | SELL | $1M+ | 2.7M | $6.05 | Sep 28, 2024 |
| Malievskaia Ekaterina | 10% Owner | SELL | $100K–$500K | 31K | $7.90 | May 22, 2024 |
| Goldsmith George Jay | 10% Owner | SELL | $100K–$500K | 31K | $7.90 | May 22, 2024 |
| Goldsmith George Jay | 10% Owner | SELL | $500K+ | 69K | $8.61 | Apr 18, 2024 |
| Malievskaia Ekaterina | 10% Owner | SELL | $500K+ | 69K | $8.61 | Apr 18, 2024 |
| Goldsmith George Jay | 10% Owner | SELL | $100K–$500K | 52K | $8.96 | Apr 2, 2024 |
| Malievskaia Ekaterina | 10% Owner | SELL | $100K–$500K | 52K | $8.96 | Apr 2, 2024 |
| Malievskaia Ekaterina | 10% Owner | SELL | $100K–$500K | 52K | $8.65 | Apr 1, 2024 |
| Goldsmith George Jay | 10% Owner | SELL | $100K–$500K | 52K | $8.65 | Apr 1, 2024 |
| Malievskaia Ekaterina | Director | SELL | $500K+ | 59K | $10.29 | Feb 27, 2024 |
| Goldsmith George Jay | Director | SELL | $500K+ | 59K | $10.29 | Feb 27, 2024 |
| Malievskaia Ekaterina | Director | SELL | $500K+ | 85K | $10.58 | Feb 8, 2024 |
| Goldsmith George Jay | Director | SELL | $500K+ | 85K | $10.58 | Feb 8, 2024 |
| Goldsmith George Jay | Director | SELL | $500K+ | 92K | $8.19 | Jan 23, 2024 |
| Malievskaia Ekaterina | Director | SELL | $500K+ | 92K | $8.19 | Jan 23, 2024 |
| Goldsmith George Jay | Director | SELL | $500K+ | 95K | $8.88 | Jan 4, 2024 |
| Malievskaia Ekaterina | Director | SELL | $500K+ | 95K | $8.88 | Jan 4, 2024 |
| Malievskaia Ekaterina | Chief Innovation O… | GRANT | N/A | 42K | — | Mar 31, 2022 |
| Malievskaia Ekaterina | Chief Innovation O… | SELL | $100K–$500K | 13K | $12.48 | Mar 31, 2022 |
| Goldsmith George Jay | CEO | GRANT | N/A | 42K | — | Mar 31, 2022 |
| Goldsmith George Jay | CEO | SELL | $100K–$500K | 13K | $12.48 | Mar 31, 2022 |
| Norton David Y | Director | SELL | $15K–$50K | 3K | $12.48 | Mar 31, 2022 |
| Jenkins Annalisa | Director | SELL | $15K–$50K | 3K | $12.48 | Mar 31, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 136 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Deep Track Capital, LP | 7.3M | $1M+ | SH |
| GMT CAPITAL CORP | 2.8M | $1M+ | SH |
| TORONTO DOMINION BANK | 2.5M | $1M+ | SH |
| ARK Investment Management LLC | 2.2M | $1M+ | SH |
| Jefferies Financial Group Inc. | 1.6M | $1M+ | SH |
| Eagle Health Investments LP | 1.5M | $1M+ | SH |
| Aisling Capital Management LP | 1.2M | $1M+ | SH |
| Ally Bridge Group (NY) LLC | 1.1M | $1M+ | SH (Call) |
| Siren, L.L.C. | 1.0M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 968K | $1M+ | SH |
| Propel Bio Management, LLC | 862K | $1M+ | SH |
| Point72 Asset Management, L.P. | 845K | $1M+ | SH |
| Kalehua Capital Management LLC | 820K | $1M+ | SH |
| PFM Health Sciences, LP | 780K | $1M+ | SH |
| NEXTBio Capital Management LP | 753K | $1M+ | SH |
| CenterBook Partners LP | 579K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 570K | $1M+ | SH |
| BlackRock, Inc. | 527K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 470K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 470K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Feb 17, 2026
5.0%
4.8M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G/A · Nov 14, 2025
3.2%
3.2M shares
Nantahala Capital Management, LLC
SC 13G/A · Nov 14, 2025
3.6%
3.5M shares
SC 13D/A · Oct 29, 2025
6.0%
5.8M shares
SC 13G/A · Aug 14, 2025
9.9%
9.5M shares
SC 13G/A · Aug 14, 2025
1.0%
965K shares
Nantahala Capital Management, LLC
SC 13G · Aug 14, 2025
6.2%
5.9M shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G/A · Aug 14, 2025
9.9%
9.5M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G/A · May 15, 2025
6.6%
6.3M shares
SC 13G · May 15, 2025
8.3%
7.9M shares
Integrated Core Strategies (US) LLC
SC 13G/A · May 7, 2025
2.1%
2.0M shares
SC 13G/A · Apr 15, 2025
2.4%
2.2M shares
SC 13D/A · Mar 5, 2025
7.5%
6.9M shares
SC 13G/A · Feb 14, 2025
1.3%
899K shares
SC 13G/A · Feb 14, 2025
2.6%
2.4M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Feb 6, 2025
3.4%
3.1M shares
SC 13G · Jan 17, 2025
10.0%
9.3M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
3.3%
2.3M shares
SC 13G/A · Nov 14, 2024
7.7%
6 shares
SC 13D/A · Sep 27, 2024
10.1%
6.9M shares
Integrated Core Strategies (US) LLC
SC 13G · Apr 11, 2024
5.7%
3.9M shares
COMPASS Pathways plc (Subject)
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G · Jan 2, 2024
4.9%
6 shares
SC 13G · Aug 28, 2023
3.1%
1.9M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G · Aug 25, 2023
5.1%
3.2M shares
SC 13G/A · Feb 14, 2022
3.1%
1.3M shares